•  
  •  
  •  
  •  

2026-08-05 14:17:35

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  PanaceaBiotec

Stock Report

  • Panacea Biotec Ltd posts consolidated PAT of Rs. 52 lakhs in Q4FY26
  • Panacea Biotec Ltd receives LoA from CMSS
  • Phase III Clinical Trial of DengiAll® by ICMR and Panacea Biotec - Completion of enrollment of study participants
  • Panacea Biotec Ltd receives acceptance from CMSS for supply of bOPV
  • Panacea Biotec Ltd receives LoA from UNICEF
  • Panacea Biotec Launches India's first 100% toxin-free and safe NikoMom Baby Skin Care
  • Panacea Biotec Ltd updates on arbitration settlement with Apotex Inc
  • Panacea Biotec Ltd receives additional award from UNICEF for supply of bOPV
  • Panacea Biotec Pharma Ltd launches baby daipers and wipes under brand name 'NikoMom'
  • Panacea Biotec receives LoA from UNICEF for supply of 115 million doses of bOPV
  • DFC Commits US$20 Million Long-Term Loan to Panacea Biotec Towards Capacity-Expansion Project for Hexavalent Vaccine
  • Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany
  • Panacea Biotec Ltd Q1 FY2024 consolidated PAT at Rs. 10.98 crore
  • Panacea Biotec launches new range of pediatric food and nutritional products in India
  • Panacea Biotec Ltd Q3 FY2023 consolidated net profit up at Rs. 19.37 crores
  • Panacea Biotec donates 125,000 doses of Easyfive-TT to Ministry of Health, Republic of Cuba for use in the National Health System
  • Panacea Biotec receives UNICEF & PAHO awards for supply of Pentavalent Vaccine
  • Panacea Biotec Pharma Ltd's Baddi plant classified as OAI by USFDA
  • Panacea Biotec Ltd consolidated Q1 FY2022-23 loss at Rs. 56.14 crores
  • Panacea Biotec Ltd Q4FY22 consolidated PAT at Rs. 1237.47 crores
  • Panacea Biotec Ltd appoints additional director
  • Panacea Biotec Ltd announces resignation of Non-Executive Nominee Director
  • Mankind Pharma acquires Panacea Biotec's Domestic Pharmaceutical Formulation Brands
  • CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025